EUVIMEDEUVIMED entdecken
Crossref

Immunotherapy Targeting CCR8+ Regulatory T Cells Induces Antitumor Effects via Dramatic Changes to the Intratumor CD8+ T Cell Profile

Azumi Ueyama, Wataru Nogami, Kunitaka Nashiki, Miya Haruna, Hiroto Miwa, Masaki Hagiwara iD, Morio Nagira, Hisashi Wada iD, Yoji Nagira

The Journal of Immunology · 2023

DOI: 10.4049/jimmunol.2300067 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Immunology, 2023. Verfasst von Azumi Ueyama und 8 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory for Bio-Drug Discovery, Shionogi & Co., Ltd., Toyonaka, Japan. Hauptthemen laut MEDLINE: T-Lymphocytes, Regulatory, Neoplasms. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 31 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Regulatory T cells (Tregs) contribute to the formation of a tumor-immunosuppressive microenvironment. CCR8 is reportedly selectively expressed in tumor Tregs, and an anti-CCR8 Ab can exert potent antitumor effects by eliminating intratumor Tregs in murine tumor models. In this study, we analyzed changes to intratumor immunity after anti-CCR8 Ab administration, especially in CD8+ T cells, which are involved in cancer cell killing, using the CT26 colorectal carcinoma mouse model. Immunophenotyping of tumor-infiltrating cells by mass cytometry after Ab administration on day 5 of tumor inoculation revealed that CD8+ T cell subsets were dramatically altered in the CCR8 Ab–treated group, with an increase in naive cells and nonexhausted effector cells and a decrease in exhausted cells with high expression levels of TOX. These results were corroborated with flow cytometry analysis. Delayed administration of the anti-CCR8 Ab on day 9 or 12, when the amount of CCR8+ Tregs and CD8+ T cell exhaustion were more progressed, also resulted in a decrease in exhausted CD8+ T cells, leading to tumor regression. Finally, we confirmed that high CCR8+ Treg infiltration was associated with high TOX expression in CD8+ T cells in human cancer patients. In conclusion, administration of an anti-CCR8 Ab can dramatically alter the activation and exhaustion state of intratumor CD8+ T cells, resulting in strong antitumor effects. In cancer patients with an advanced tumor-immunosuppressive environment, CD8+ T cell exhaustion has progressed along with CCR8+ Treg induction. Therefore, targeted depletion of CCR8+ Tregs is expected to be effective in these patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

T-Lymphocytes, RegulatoryNeoplasmsHumansAnimalsMiceCD8-Positive T-LymphocytesImmunotherapyTumor Microenvironment

Autor:innen und Institutionen

  • Laboratory for Bio-Drug Discovery, Shionogi & Co., Ltd., Toyonaka, Japan.
  • Department of Clinical Research in Tumor Immunology, Osaka University, Suita, Japan.

ORCID-Profile: Masaki Hagiwara, Hisashi Wada

Zitieren

APA

Ueyama, A., Nogami, W., Nashiki, K., Haruna, M., Miwa, H., Hagiwara, M., Nagira, M., Wada, H., & Nagira, Y. (2023). Immunotherapy Targeting CCR8+ Regulatory T Cells Induces Antitumor Effects via Dramatic Changes to the Intratumor CD8+ T Cell Profile. The Journal of Immunology. https://doi.org/10.4049/jimmunol.2300067

Vancouver

Ueyama A, Nogami W, Nashiki K, Haruna M, Miwa H, Hagiwara M, et al. Immunotherapy Targeting CCR8+ Regulatory T Cells Induces Antitumor Effects via Dramatic Changes to the Intratumor CD8+ T Cell Profile. The Journal of Immunology. 2023. doi:10.4049/jimmunol.2300067

BibTeX
@article{Ueyama2023,
  author = {Ueyama, Azumi and Nogami, Wataru and Nashiki, Kunitaka and Haruna, Miya and Miwa, Hiroto and Hagiwara, Masaki and Nagira, Morio and Wada, Hisashi and Nagira, Yoji},
  title = {Immunotherapy Targeting CCR8+ Regulatory T Cells Induces Antitumor Effects via Dramatic Changes to the Intratumor CD8+ T Cell Profile},
  journal = {The Journal of Immunology},
  year = {2023},
  doi = {10.4049/jimmunol.2300067}
}
Kostenlos starten →